SCHEMBL27493170

SCHEMBL27493170

C=CC(N1CCC(C(=O)c2ccc(F)cc2)CC1)S(=O)(=O)c1ccc(CNC(=O)c2ccc(Cl)cc2)s1

nearest known ligand 0.45

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ MAPK9 P45984 1/20 0.45
▸ MAPK10 P53779 1/20 0.45
▸ HSD11B1 P28845 2/20 0.43
▸ MGLL Q99685 1/20 0.43
▸ MEN1 O00255 2/20 0.42
▸ KMT2A Q03164 2/20 0.42
▸ TP53 P04637 2/20 0.39
▸ LMNA P02545 1/20 0.39
▸ MAPT P10636 1/20 0.39
▸ L3MBTL1 Q9Y468 1/20 0.39
▸ BCL2 P10415 1/20 0.38
▸ BCL2L1 Q07817 1/20 0.38
▸ SMN1; SMN2 Q16637 1/20 0.37
▸ ALDH1A1 P00352 1/20 0.37
▸ POLB P06746 1/20 0.37
▸ CYP2C19 P33261 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27495911 0.86 BCL2 (0.45) MAPK9MAPK10MEN1KMT2ATP53
SCHEMBL27495526 0.84 MAPK9 (0.49) MAPK9MAPK10MEN1KMT2ALMNA
SCHEMBL2423768 0.83 MAPK9 (0.60) MAPK9MAPK10HSD11B1MGLLMEN1
SCHEMBL27478299 0.83 MAPK9 (0.46) MAPK9MAPK10MEN1KMT2ALMNA
SCHEMBL27479501 0.81 MAPK9 (0.47) MAPK9MAPK10MEN1KMT2ALMNA
SCHEMBL27495909 0.80 MAPK9 (0.45) MAPK9MAPK10MEN1KMT2ABCL2
SCHEMBL27494743 0.79 MAPK9 (0.63) MAPK9MAPK10MEN1KMT2ALMNA
SCHEMBL27479119 0.79 MAPK9 (0.63) MAPK9MAPK10MEN1KMT2ALMNA
SCHEMBL2426036 0.78 MAPK9 (0.64) MAPK9MAPK10MEN1KMT2ATP53
SCHEMBL27560179 0.77 MAPK9 (0.41) MAPK9MAPK10MEN1KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1189467-C Pharmaceutically active sulfonamide derivatives APPLIED RES SYSTEM ARS HOLDING (AN) 2005-02-16 — — CN disclosed
Send feedback